Rationale for the use of low-intensity photodynamic therapy in stage I basal cell skin carcinoma
Acta Biomedica Scientifica · 02.08.2026 · 11 (3) · 88-96
DOI: 10.29413/abs.2026-11.3.11 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomedica Scientifica, online erschienen am 02.08.2026. Verfasst von A. V. Shcherbatykh und 2 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Background
The paper describes a method of low intensity photodynamic therapy (LIPDT) for the treatment of superficial basal cell skin cancer (SBCSC) stage I using topical application of the photosensitizer Photoditazine gel® or intravenous Photoditazine® solution. LIPDT is the treatment of choice in medical organizations lacking laser equipment, specialized facilities, or for remote use (in distant areas). It can also be used as an adjunct to other treatment methods.
Aim
To provide a theoretical rationale for the use of a LIPDT device with Photoditazine® and Photoditazine gel® for the treatment of SBCSC. Materials and methods . The developed device consists of the following elements: a battery, a control board, a DC-DC voltage converter, a microcontroller, a driver, and an LED matrix. The mechanism of the device is based on the classical PDT method but has several key differences: automatic mode (eliminating the need for manual adjustment), low output radiation power (which prevents oxygen depletion in tumor tissue), and the ability to function under conditions unsuitable for standard PDT.
Conclusion
The proposed LIPDT method for treating stage I SBCSC will reduce treatment costs while maintaining the effectiveness of the existing standard PDT method.
Zitieren
APA
Shcherbatykh, A. V., Belonogov, A. V., & Tolmachev, K. V. (2026). Rationale for the use of low-intensity photodynamic therapy in stage I basal cell skin carcinoma. Acta Biomedica Scientifica, 11(3), 88-96. https://doi.org/10.29413/abs.2026-11.3.11
Vancouver
Shcherbatykh AV, Belonogov AV, Tolmachev KV. Rationale for the use of low-intensity photodynamic therapy in stage I basal cell skin carcinoma. Acta Biomedica Scientifica. 2026;11(3):88-96. doi:10.29413/abs.2026-11.3.11
BibTeX
@article{Shcherbatykh2026,
author = {Shcherbatykh, A. V. and Belonogov, A. V. and Tolmachev, K. V.},
title = {Rationale for the use of low-intensity photodynamic therapy in stage I basal cell skin carcinoma},
journal = {Acta Biomedica Scientifica},
year = {2026},
volume = {11},
number = {3},
pages = {88--96},
doi = {10.29413/abs.2026-11.3.11}
}
EUVIMED